Acadia Pharmaceuticals Stock Price on May 10, 2024
| ACAD Stock | USD 15.54 0.28 1.77% |
Below is the normalized historical share price chart for ACADIA Pharmaceuticals extending back to May 27, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ACADIA Pharmaceuticals stands at 15.54, as last reported on the 23rd of May, with the highest price reaching 15.90 and the lowest price hitting 15.20 during the day.
If you're considering investing in ACADIA Stock, it is important to understand the factors that can impact its price. ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of -0.2, which signifies that the company had a -0.2% return per unit of risk over the last 3 months. ACADIA Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ACADIA Pharmaceuticals' market risk adjusted performance of (5.29), and Variance of 10.55 to double-check the risk estimate we provide.
At present, ACADIA Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3 B, whereas Capital Stock is forecasted to decline to about 17.1 K. . At present, ACADIA Pharmaceuticals' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 322.45, whereas Price Earnings Ratio is projected to grow to (79.51). ACADIA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of May 2004 | 200 Day MA 23.2807 | 50 Day MA 17.1364 | Beta 0.416 |
ACADIA |
Sharpe Ratio = -0.2027
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACAD |
Estimated Market Risk
| 3.3 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.67 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ACADIA Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ACADIA Pharmaceuticals by adding ACADIA Pharmaceuticals to a well-diversified portfolio.
Price Book 6.5412 | Enterprise Value Ebitda (36.01) | Price Sales 3.8877 | Shares Float 107.8 M | Wall Street Target Price 27.28 |
ACADIA Pharmaceuticals Main Headline on 10th of May 2024
Acadia shares price target cut on Q1 revenue miss by investing.com
Acadia shares price target cut on Q1 revenue miss
ACADIA Pharmaceuticals Valuation on May 10, 2024
It is possible to determine the worth of ACADIA Pharmaceuticals on a given historical date. On May 10, 2024 ACADIA was worth 15.3 at the beginning of the trading date compared to the closed value of 15.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ACADIA Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find ACADIA Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACADIA Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ACADIA Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 17.50 | 17.50 | 15.17 | 15.21 | 5,281,555 | |
05/10/2024 | 15.30 | 15.53 | 15.11 | 15.25 | 2,310,110 |
| 15.45 | 15.56 | 15.13 | 15.18 | 1,449,800 |
| Backtest ACADIA Pharmaceuticals | | | ACADIA Pharmaceuticals History | | | ACADIA Pharmaceuticals Valuation | Previous | Next |
ACADIA Pharmaceuticals Trading Date Momentum on May 10, 2024
| On May 13 2024 ACADIA Pharmaceuticals was traded for 15.18 at the closing time. The top price for the day was 15.56 and the lowest listed price was 15.13 . The trading volume for the day was 1.4 M. The trading history from May 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.46% . The overall trading delta against the current closing price is 2.95% . |
ACADIA Pharmaceuticals Fundamentals Correlations and Trends
By evaluating ACADIA Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ACADIA Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ACADIA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ACADIA Pharmaceuticals Stock history
ACADIA Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ACADIA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ACADIA Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ACADIA Pharmaceuticals stock prices may prove useful in developing a viable investing in ACADIA Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 163.8 M | 172 M | |
| Net Loss | -194.4 M | -204.1 M |
ACADIA Pharmaceuticals Quarterly Net Working Capital |
|
ACADIA Pharmaceuticals Stock Technical Analysis
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ACADIA Pharmaceuticals Period Price Range
Low | May 10, 2024
| High |
15.30 | 15.25 |
ACADIA Pharmaceuticals May 23, 2024 Market Strength
Market strength indicators help investors to evaluate how ACADIA Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ACADIA Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying ACADIA Pharmaceuticals stock market strength indicators, traders can identify ACADIA Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 62475.61 | |||
| Daily Balance Of Power | (0.12) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 15.32 | |||
| Day Typical Price | 15.3 | |||
| Price Action Indicator | (0.1) | |||
| Period Momentum Indicator | 0.29 |
ACADIA Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ACADIA Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of ACADIA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ACADIA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.02) | |||
| Treynor Ratio | (5.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ACADIA Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.Note that the ACADIA Pharmaceuticals information on this page should be used as a complementary analysis to other ACADIA Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is ACADIA Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 4.949 | Quarterly Revenue Growth 0.738 | Return On Assets (0) | Return On Equity (0) |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.